Thierry Bogaert BVBA, represented by Thierry Bogaert, PhD
Managing director and Chief Executive Officer (CEO)

Thierry Bogaert is a graduate from the Universtiy of Ghent and received an MSc degree from the University of Manitoba, Canada and a PhD from the Medical Research Council, Laboratory of Molecular Biology, Cambridge, United Kingdom. He held faculty positions at the MRC-LMB in Cambridge and the Medical Faculty of the University of Ghent. He founded Devgen in 1997 and has led the company since. He is actively involved with both the Crop Protection and Human Therapeutics businesses, having been instrumental in setting strategic direction and forging key collaborations in both areas that support the company goals and objectives.

Wim Goemaere
Chief Financial Officer

Stephane Wilmes
General Counsel

Stephane Wilmes holds a law degree from the University of Ghent, Belgium and graduated from the Ecole Supérieure des Sciences Economiques et Commerciales (ESSEC), France. He is the former general counsel of Innogenetics NV where he gained over 5 years of experience in the biotech field. Prior to joining Innogenetics, he worked at Baker & McKenzie Brussels where his practise included mergers and acquisitions, commercial contract drafting and litigation. He joined Devgen in January 2006.

Ann Viaene, PhD
IP counsel, head of intellectual property central department

Ann Viaene holds an MSc in biotechnology from Ghent University, a PhD in sciences from the University of Leuven and is a qualified European patent attorney. Before joining Devgen in 2004, she worked for 6 years in the private practice firm Declercq, Brandt en Partners.

Sabine Drieghe
Human Resources Director

Sabine Drieghe, Human Resources Director, received an Msc in Agricultural and Chemical engineering at the University of Ghent. Prior to joining Devgen in 2001, she headed the laboratory of the Department of Crop Protection at the University of Ghent.

Stefan Frey
Chief Operating Officer

Mr. Stefan Frey has obtained his MBA in 1979 in Germany. He joined Bayer Group as Operations Manager, and was subsequently appointed General Manager for several business groups of Bayer worldwide. He joined Bayer Crop Protection Division in the overseas Division and started his international career as Operations Manager in South Africa. He was subsequently appointed General Manager for Bayer's subsidiary in Hong Kong, Philippines and Australia. In 1994, he became Area Director Europe, Middle East and Africa with FMC, where he was responsible for the Crop Protection Business with focus on the introduction of new herbicides and building market access through alliances. Later he became Director of Global Herbicides, Business and Technology Affaires within FMC and was involved in the development of a global herbicide strategy. Before joining Devgen, he held the position of Area Director Asia Pacific.

Hilde Windels BVBA, represented by Hilde Windels
Executive director and Head of Human Therapeutics Business

Hilde Windels has a master in business economics from the University of Leuven. She has been with Devgen since the end of 1998. Previously she was regionally responsible for corporate banking at BBL (now ING).

Dirk Leysen, PhD
Head of medicinal chemistry, research and development Human Therapeutics

Before joining Devgen, Dirk Leysen was section head medicinal chemistry for Organon NV, The Netherlands. He has 22 years of experience in drug discovery and development with focus on medicinal chemistry, within the therapeutic areas of infection, schizophrenia, depression and anxiety, infertility, contraception and hormone replacement therapy, immunology, and cardiovascular. Dr. Leysen holds a PhD in pharmaceutical chemistry from the University of Antwerp, Belgium. Currently he also holds a position of professor in chemical biology at Maastricht University and the University of Eindhoven, The Netherlands.